Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D
暂无分享,去创建一个
J. Knight | A. Sadovnick | G. Ebers | B. Herrera | L. Handunnetthi | D. Dyment | M. Lincoln | S. Ramagopalan | N. Maugeri | S. Orton | G. DeLuca | M. Chao | Gabriele C. DeLuca
[1] C. Duijn,et al. Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis , 2008, Nature Genetics.
[2] C. Duijn,et al. EVI5 is a risk gene for multiple sclerosis , 2008, Genes and Immunity.
[3] M. Cantorna,et al. The vitamin D receptor is required for iNKT cell development , 2008, Proceedings of the National Academy of Sciences.
[4] G. Ebers. Environmental factors and multiple sclerosis , 2008, The Lancet Neurology.
[5] P. Menheere,et al. Vitamin D as an immune modulator in multiple sclerosis, a review , 2008, Journal of Neuroimmunology.
[6] G. Ebers,et al. Genes for multiple sclerosis , 2008, The Lancet.
[7] T. Hudson,et al. An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus , 2007, Proceedings of the National Academy of Sciences.
[8] S. Gabriel,et al. Risk alleles for multiple sclerosis identified by a genomewide study. , 2007, The New England journal of medicine.
[9] A. Morris,et al. The Inheritance of Resistance Alleles in Multiple Sclerosis , 2007, PLoS genetics.
[10] H. Harbo,et al. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. , 2007, Nature genetics.
[11] A. Ascherio,et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. , 2006, JAMA.
[12] C. Banwell,et al. Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor , 2006, Nucleic acids research.
[13] W. Reith,et al. Regulation of MHC class II gene expression by the class II transactivator , 2005, Nature Reviews Immunology.
[14] M. Z. Cader,et al. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. , 2005, Human molecular genetics.
[15] P. Rothwell,et al. Timing of birth and risk of multiple sclerosis: population based study , 2004, BMJ : British Medical Journal.
[16] J. Hillert,et al. Modes of action of HLA-DR susceptibility specificities in multiple sclerosis. , 2004, American journal of human genetics.
[17] Wyeth W. Wasserman,et al. JASPAR: an open-access database for eukaryotic transcription factor binding profiles , 2004, Nucleic Acids Res..
[18] D. Kwiatkowski,et al. Allele-specific repression of lymphotoxin-alpha by activated B cell factor-1. , 2004, Nature genetics.
[19] N. Risch,et al. Twin concordance and sibling recurrence rates in multiple sclerosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[20] Tariq Ahmad,et al. Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC. , 2003, Human molecular genetics.
[21] Dominic P. Kwiatkowski,et al. In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading , 2003, Nature Genetics.
[22] M. Holick. Vitamin D: A millenium perspective , 2003, Journal of cellular biochemistry.
[23] G. Rosati,et al. The worldwide prevalence of multiple sclerosis , 2002, Clinical Neurology and Neurosurgery.
[24] B. Dawson-Hughes,et al. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. , 2002, Bone.
[25] A. Abbas,et al. The enemy within: keeping self-reactive T cells at bay in the periphery , 2002, Nature Reviews Immunology.
[26] A. Kruger,et al. Sequence analysis of the DRB1 promoter reveals limited polymorphism with no influence on gene expression , 2001, Genes and Immunity.
[27] N. Jablonski,et al. The evolution of human skin coloration. , 2000, Journal of human evolution.
[28] N. Risch,et al. Canadian Collaborative Project on Genetic Susceptibility to MS, Phase 2: Rationale and Method , 1998, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[29] G. Andersson,et al. Evolution of the human HLA-DR region. , 1998, Frontiers in bioscience : a journal and virtual library.
[30] M. Elian,et al. Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis , 1997, Journal of neurology, neurosurgery, and psychiatry.
[31] F. Muntoni,et al. Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles. , 1997, American journal of human genetics.
[32] J. Hillert,et al. The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele. , 1995, Tissue antigens.
[33] N. Risch,et al. A genetic basis for familial aggregation in multiple sclerosis , 1995, Nature.
[34] J. Herbert,et al. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis , 1994, Neurology.
[35] M. Waugh,et al. Regulation of human monocyte HLA-DR and CD4 antigen expression, and antigen presentation by 1,25-dihydroxyvitamin D3. , 1990, Blood.
[36] R. Russell,et al. Constitutive and inducible expression of HLA class II determinants by human osteoblast-like cells in vitro. , 1990, The Journal of clinical investigation.
[37] D. English,et al. The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart. , 1988, Brain : a journal of neurology.
[38] E. Acheson,et al. SOME COMMENTS ON THE RELATIONSHIP OF THE DISTRIBUTION OF MULTIPLE SCLEROSIS TO LATITUDE, SOLAR RADIATION, AND OTHER VARIABLES , 1960, Acta psychiatrica Scandinavica. Supplementum.
[39] W. L. Benedict,et al. Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.